Located within CSLB’s GSPV department, the Director, Global Safety Lead, Formulation Safety provide expertise on all aspects of –clinical safety throughout the entire lifecycle of a product with special emphasis on ongoing evaluation of safety information
Overview: The Manager, Clinical Trial Authorization (CTA) is responsible for ensuring that CTA activities for assigned clinical studies are planned, governed, and overseen in line with CSL regulatory expectations, quality standards, and development timelines. Reporting to the
The Director Non-Clinical Due Diligence & External Evaluations provides scientific leadership for nonclinical due diligence supporting CSL’s in‑licensing, acquisitions, and strategic collaborations. The role ensures integrated, objective, and decision‑relevant evaluations of nonclinical pharmacology, PK/QSP, and toxicology
Director, CMC Strategy & Technology Transfer The Director of CMC Strategy & Technology Transfer is responsible for defining and executing the Chemistry, Manufacturing, and Controls (CMC) strategy across development and commercialization. This role ensures seamless transition of
CSL is transforming its R&D organization to accelerate innovation and create greater impact for patients. With a streamlined, project-led structure and a focus on collaboration, were building a future-ready team that excels in dynamic biotech ecosystems.